欢迎光临散文网 会员登陆 & 注册

【热门产品推荐】艾沃利单抗 ,Omburtamab, AntibodySystem Laboratories

2023-06-08 08:46 作者:AtaGenix-普健生物  | 我要投稿

艾沃利单抗 ,Omburtamab,CAS:1895083-75-6, AntibodySystem Laboratories

 

货号:DHJ04002

产品链接:http://www.atagenix.com/product_detail-75194.html

别名:8H9, Mab 8H9, CAS: 1895083-75-6

简介:

Omburtamab 是一种 anti-CD276 (也被称为 B7-H3) 的单克隆抗体,CD276 是一种在人类实体肿瘤中表达的 B7/CD28 免疫球蛋白家族成员。Omburtamab 可以与肿瘤组织相结合,用于各种癌症的研究。

货号:DHJ04002

产品品牌:Antibodysystem

通用名:Omburtamab

纯度:>95% by SDS-PAGE.

浓度:1mg/ml

Formulationicon:0.01M PBS, pH 7.4.

别名:8H9, Mab 8H9

靶点;物种:Human CD276/B7-H3

种类:Mus musculus

受体鉴定:IgG1-kappa

CAS: 1895083-75-6

存储条件:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

参考文献:

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies. PMID: 36371226
Antibodies to watch in 2020. PMID: 31847708
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine. PMID: 31481583
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic index. PMID: 33047248
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. PMID: 31405921
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes. PMID: 33514401
Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors. PMID: 34857661
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study. PMID: 33119478
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma. PMID: 36853490
Radioimmunoscintigraphy and pre-treatment dosimetry of 131I-omburtamab for planning treatment of leptomeningeal disease. PMID: 36759197
Antibodies to watch in 2019. PMID: 30516432
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes. PMID: 30879172
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy. PMID: 33533945
Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma. PMID: 32977309
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody. PMID: 34601396
Evaluation of a patient-specific algorithm for predicting distribution for convection-enhanced drug delivery into the brainstem of patients with diffuse intrinsic pontine glioma. PMID: 33990084

【热门产品推荐】艾沃利单抗 ,Omburtamab, AntibodySystem Laboratories的评论 (共 条)

分享到微博请遵守国家法律